Related Experiment Video
Updated: May 7, 2026

07:00
Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish
Published on: October 8, 2018
Adult zebrafish model for pneumococcal pathogenesis.
Anni Saralahti1, Hannaleena Piippo, Mataleena Parikka
1Institute of Biomedical Technology, BioMediTech, University of Tampere, FI-33014 Tampere, Finland.
Developmental and Comparative Immunology
|October 1, 2013
Summary
The adult zebrafish model effectively replicates Streptococcus pneumoniae infections, including meningitis, and aids in studying host-pathogen interactions. However, it is not suitable for investigating adaptive immunity or developing new vaccines.
Area of Science:
- Microbiology
- Infectious Diseases
- Zebrafish Models
Background:
- Streptococcus pneumoniae causes pneumonia, septicemia, and meningitis.
- Optimal treatments and prevention are limited by incomplete understanding of host and bacterial factors.
Purpose of the Study:
- To evaluate the adult zebrafish (Danio rerio) as a model for investigating pneumococcal disease pathophysiology.
- To examine host and bacterial factors contributing to pneumococcal pathogenesis.
Main Methods:
- Adult zebrafish were infected with Streptococcus pneumoniae strain TIGR4 via intraperitoneal and intramuscular routes.
- Isogenic mutant strains lacking key virulence factors were used.
- Rag1 mutant zebrafish, lacking adaptive immunity, were employed to assess immune response roles.
Main Results:
- Intraperitoneal and intramuscular injections of TIGR4 caused dose-dependent, fulminant infections.
- Mutant strains lacking capsule, autolysin, or pneumolysin showed reduced virulence.
- Infection led to bloodstream proliferation, blood-brain barrier penetration, and meningitis.
- Clearance in zebrafish primarily relies on innate immune responses.
Conclusions:
- The adult zebrafish is a viable model for studying pneumococcal infection pathogenesis and host-bacterial interactions.
- The model is not suitable for research on adaptive immunity or vaccine development against pneumococcal disease.

